Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
European Heart Journal|May 11, 2023
Rapid, accurate publication and dissemination of clinical trial results: benefits and challengesFaiez Zannad, Filippo Crea, John Keaney, et al.
Kidney Medicine|February 2, 2026
Conceptual Development Informing the Kidney Failure Patient Life Goals SurveyClaudia Dahlerus, Noelle E Carlozzi, Richard A Hirth, et al.
Cancer|April 11, 2016
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapyUrsula A Matulonis, Philipp Harter, Charlie Gourley, et al.
Frontiers in Nutrition|May 27, 2021
RNA Sequencing Reveals Key Metabolic Pathways Are Modified by Short-Term Whole Egg ConsumptionAmanda E Bries, Joe L Webb, Brooke Vogel, et al.
International Journal of Environmental Research and Public Health|September 27, 2023
Physical Activity and Exercise Experience in Spanish and US Men with Fibromyalgia: A Qualitative Cross-Cultural StudyPilar Montesó-Curto, Loren Toussaint, Angela Kueny, et al.
Frontiers in Medicine|June 4, 2024
Emotional experiences and gender roles of men with fibromyalgia syndrome: a cross-cultural qualitative studyPilar Montesó-Curto, Loren Toussaint, Angela Kueny, et al.
British Journal of Cancer|November 9, 2016
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancerJonathan A Ledermann, Philipp Harter, Charlie Gourley, et al.
Plos One|November 3, 2020
Whole egg consumption increases gene expression within the glutathione pathway in the liver of Zucker Diabetic Fatty ratsJoe L Webb, Amanda E Bries, Brooke Vogel, et al.
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
The Lancet. Oncology|September 13, 2016
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trialJonathan A Ledermann, Philipp Harter, Charlie Gourley, et al.
Pageof 7